The effect of OPC-4392, a partial dopamine receptor agonist on negative symptoms: results of an open study.
Gerbaldo
H
H
Department of Psychiatry, Hospital of the University Frankfurt/M., FRG.
Demisch
L
L
Lehmann
C O
CO
Bochnik
J
J
D000328:Adult; D015259:Dopamine Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006212:Hallucinations; D006801:Humans; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D015363:Quinolones / Q000009:adverse effects / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology
D015259:Dopamine Agents; D010879:Piperazines; D015363:Quinolones; C054574:OPC 4392